2017 MDIC Graduates


2017 MDIC Graduates

Simpler Links
Superlative Biosciences
Costello Prosthetic Warmers

2017 MDIC Graduates Update 

Several of the 2017 Medical Device Innovation Challenge participants are continuing to move forward to include Costello Prosthetic Warmers which is now included in the LaunchNY program and EndoGlow, now a CNY Biotech Accelerator client, who recently received funding.  Below are more details:

Costello Prosthetic Warmers (CPW), LLC, is a medical device startup dedicated to making life more comfortable and less painful for amputees. It is founded by Bryan Costello, a lower leg amputee who invented its first product, the Costello Heatsleeve™, to ease his own suffering from phantom limb pain, nerve pain and coldness in his residual limb.

The following are key milestones accomplished during and post-graduation from the 2017 MDIC Program:

  • September 2018: Participant in Launch NY
  • July 2018: Accepted into The Tech Garden 
  • June 2018: Prototype III Beta-Testing and Accepted as Stonybrook Participant in Strategic Partnership for Industrial Resurgence (SPIR) 
  • May 2018: Prototype IV Design for Manufacturing Started; Kirstie Ennis, veteran above the knee amputee, tested Prototype III while climbing Denali in Alaska.
  • Apr 2018:  Queen's University, Kingston, Ontario Collaboration for Prototype III completed.
  • Mar 2018: Featured in Empire State Development
  • Jan - Apr 2018: Introduction to Washington VA via Congressman John Katko's office
  • December 2017: Upstate MIND MDIC Graduate
  • October 2017: Winner, 2017 MEDTECH Pitch Competition


  • EndoGlow has benefited greatly from participation in the MDIC program.  EndoGlow, founded by Paula Doyle, MD and Jay Reeder, PhD, has teamed with Two Wins Capital to provide business management and product development expertise in addition to capital infusion. 
  • EndoGlow and the University of Rochester won a FuzeHub Manufacturing Innovation Grant which will partially fund proof of principle manufacturing and a clinical evaluation study of the GreenEgg.
  • At present product design and development have been completed, raw material sourced, and a manufacturer contracted. Company infrastructure is being formalized to establish processes for additional product development, sales, operations, and finance.
  • As a medical device company, a rigorous quality system is needed and is being developed in anticipation of registering EndoGlow and the GreenEgg with the FDA.